On Wednesday, Following Stocks were among the “Top Gainers” of U.S. Stock Market: Arrowhead Research, (NASDAQ:ARWR), Barrick Gold Corporation, (NYSE:ABX), Capnia, (NASDAQ:CAPN), Pretium Resources, (NYSE:PVG)
Arrowhead Research, (NASDAQ:ARWR), with shares gained 9.83%, closed at $7.43.
Barrick Gold Corporation, (NYSE:ABX), with shares jumped 9.58%, settled at $12.01.
Capnia, (NASDAQ:CAPN), with shares climbed 9.22%, and closed at $6.99.
Pretium Resources, (NYSE:PVG), gained 8.73%, and closed at $5.48.
Latest NEWS regarding these Stocks are depicted underneath:
Arrowhead Research Corp. (NASDAQ:ARWR)
Arrowhead Research Corp. (ARWR), has the beta value of 2.18, and its volatility for the week is 6.62%, while for the month it is 5.88%. The company has the market capitalization of $407.16M. The company holds the book value per share of 2.67, whereas cash per share is 2.33. Price to book ratio remained 2.78, while price to sale ratio is 1357.21. Analysts mean recommendation for the stock is said to be 2.30 (where 1=Buy, 5=sale).
Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The corporation’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chronic hepatitis B virus infection; and ARC-AAT, a novel unlocked nucleobase analog containing RNAi-based therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency.
Barrick Gold Corporation (NYSE:ABX)
Barrick Gold Corporation (ABX), will release its First Quarter Results on April 27th after market close, while it will conduct its Conference Call and Webcast on April 28th 4:30 pm ET.
The Conference Call will be accessible for replay until May 12th, 2015 by calling 800-408-3053 for North American callers and 905-694-9451 for International callers, Pass Code: 7049254.
Barrick Gold Corporation produces and sells gold and copper. The corporation is also involved in exploration and mine development activities. It conducts mining, development and exploration, and other activities in various countries, counting the United States, Canada, Australia, Argentina, Chile, Peru, the Dominican Republic, Papua New Guinea, Tanzania, Zambia, and Saudi Arabia.
Capnia, Inc. (NASDAQ:CAPN)
Formerly on March 23, Maxim Group, a Research Firm, has initiated its research on Capnia, Inc. (CAPN), from “Buy” rating.
Formerly on March 10, the company focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, declared financial results for the fourth quarter and twelve months ended December 31, 2014.
Key Highlights of Fourth Quarter 2014 Financial Results:
No proceed was recognized in the three months ended December 31, 2014 or December 31, 2013.
Research and development expenses in the fourth quarter of 2014 were $0.6 million, contrast to $0.4 million in the fourth quarter of 2013. The raise was primarily due to reimbursement of R&D expense of $0.3 million under the GSK license contract in the fourth quarter of 2013. The GSK license contract was terminated in the second quarter of 2014. Exclusive of this reimbursement R&D expenses were largely constant in both quarters.
Sales and marketing expenses in the fourth quarter of 2014 were $0.2 million. There were no sales and marketing expenses for the year ended December 31, 2013. The raise was primarily due to the addition of the Vice President of Sales in June 2014 and the commercial launch activities for CoSense initiated in October 2014.
Other expense in the fourth quarter of 2014 raised by $3.6 million contrast to the fourth quarter of 2013. This raise was due to an raise of $5.8 million in the fair value of the Series B warrant liability from November 18, 2014 to December 31, 2014, and a net decrease of $2.2 million in the fair value of other stock warrants.
Net loss for the fourth quarter of 2014 was $7.9 million, or a loss of $2.23 per share, contrast to a net loss of $1.0 million, or a loss of $1.82 per share, for the fourth quarter of 2013.
Capnia, Inc. develops diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow primarily in the United States. The corporation offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to the degradation of red blood cells.
Pretium Resources Inc. (NYSE:PVG)
Pretium Resources Inc. (PVG), is happy to declare that it has been issued an Environmental Assessment Certificate for its Brucejack Project by the British Columbia Minister of the Environment and Minister of Energy and Mines.
The Ministers issued the certificate with conditions that have given them the confidence to conclude that the project will be constructed, operated and decommissioned in a way that ensures no noteworthy adverse effects are likely to occur. Pretivm will address these conditions in advance of the start of mine construction which it anticipates to start this summer.
The environmental review process, which was concluded within the legislated timeframe, was led by British Columbia’s Environmental Assessment Office. The process provides for noteworthy opportunities for Aboriginal groups, government agencies and the public to provide input on the potential for environmental, economic, social, heritage and health effects from a projected project.
The federal review of the Brucejack Project by the Canadian Environmental Assessment Agency is nearing completion, with a predictable referral to the Minister of the Environment later this spring.
Pretium Resources Inc. attains, explores for, and develops precious metal resource properties in the Americas. The corporation’s mineral interests comprise of gold/copper/silver exploration projects.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
